Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

書誌詳細
出版年:	Journal of Infection in Developing Countries
主要な著者:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
フォーマット:	論文
言語:	英語
出版事項:	The Journal of Infection in Developing Countries 2024-05-01
主題:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
オンライン･アクセス:	https://jidc.org/index.php/journal/article/view/18410

類似資料

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
著者:: Luca Rinaldi, 等
出版事項: (2019-08-01)

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
著者:: Hafiza Arooba Riaz, 等
出版事項: (2023-05-01)

Liver cirrhosis: dispensary observation, the effectiveness of antiviral therapy
著者:: Y.H. Yupatau, 等
出版事項: (2022-08-01)

Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
著者:: Mira Atef, 等
出版事項: (2022-09-01)

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
著者:: El-Araby Mohamed Ibrahim Shalaby, 等
出版事項: (2023-06-01)

Topical problems of antiviral therapy for chronic hepatitis C
著者:: I G Bakulin
出版事項: (2015-11-01)

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
著者:: Karem Aline Pegoraro, 等
出版事項: (2023-11-01)

Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals
著者:: Agata Zientarska, 等
出版事項: (2021-12-01)

Combined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice
著者:: Yu. M. Ambalov, 等
出版事項: (2018-06-01)

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination
著者:: Dorota Zarębska-Michaluk, 等
出版事項: (2024-10-01)

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
著者:: Paolo Carta, 等
出版事項: (2020-05-01)

Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients
著者:: Asmaa M. Elbrolosy, 等
出版事項: (2021-03-01)

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)
著者:: Lorenza Di Marco, 等
出版事項: (2025-01-01)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
著者:: Christopher Dietz, 等
出版事項: (2022-06-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
著者:: S N Batskikh, 等
出版事項: (2018-11-01)

The impact of antiviral therapy on hepatocellular carcinoma epidemiology
著者:: Massimo Colombo, 等
出版事項: (2018-01-01)

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study
著者:: Mehdi Kashani, 等
出版事項: (2024-10-01)

Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
著者:: Shou-Wu Lee, 等
出版事項: (2022-10-01)

Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
著者:: Michiko Shimada, 等
出版事項: (2017-03-01)

The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection
著者:: D. V. Garbuzenko
出版事項: (2021-11-01)

Serum retinol-binding protein 4 as a predictor of fibrosis regression and response to direct-acting antiviral drugs in chronic hepatitis C virus patients
著者:: Hany Samir Rasmy, 等
出版事項: (2023-03-01)

Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis
著者:: Liwei Zhuang, 等
出版事項: (2021-07-01)

The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients
著者:: Meng-Yu Ko, 等
出版事項: (2025-02-01)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
著者:: Nobuyuki Toshikuni
出版事項: (2017-05-01)

Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
著者:: Chun-Hsien Chen, 等
出版事項: (2023-01-01)

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India
著者:: Sagnik Bakshi, 等
出版事項: (2025-05-01)

A study on the prevalence of HCV genotypes and the effect of direct-acting antiviral therapy on clinical and laboratory parameters in HCV-Infected patients at a tertiary care center in North India
著者:: S Muhammed Shahanas, 等
出版事項: (2024-01-01)

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
著者:: Devis Pascut, 等
出版事項: (2020-06-01)

Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study
著者:: Filomena Morisco, 等
出版事項: (2024-09-01)

Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States
著者:: Haesuk Park, 等
出版事項: (2023-04-01)

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
著者:: Hassan AM, 等
出版事項: (2018-06-01)

Virologic Tools for HCV Drug Resistance Testing
著者:: Slim Fourati, 等
出版事項: (2015-12-01)

Telemedicine and hybrid engagement models facilitate hepatitis C cascade of care during periods of healthcare disruption
著者:: Sabrina Fan, 等
出版事項: (2026-01-01)

Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
著者:: Nathalie Alazard-Dany, 等
出版事項: (2019-01-01)

Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug–Drug Interactions with Antiviral Treatments for Hepatitis C
著者:: Andreas Hintz, 等
出版事項: (2021-05-01)

Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
著者:: Sara Kishta, 等
出版事項: (2020-06-01)

Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan
著者:: Chun-Hsien Chen, 等
出版事項: (2024-01-01)

Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital
著者:: Nahed Mohammed Hawsawi, 等
出版事項: (2023-01-01)

The Natural History of Hepatitis C Virus Infection and Disease in the Era of Curative Therapy with Direct-Acting Antivirals
著者:: Maurizia Rossana Brunetto, 等
出版事項: (2025-02-01)

Genotype distribution, intravenous drug use rates and direct-acting antiviral treatment results in prisoner hepatitis C patients
著者:: Ö. Şahin, 等
出版事項: (2023-04-01)